BACKGROUND: Microlesion effect (MLE) is a commonly observed phenomenon after electrode insertion into the subthalamic nucleus (STN) for deep brain stimulation (DBS). OBJECTIVES: The aim of this study was to determine the presence of the MLE in the early postoperative period and the relationship between MLE and STN DBS. METHODS: 74 patients with Parkinson's disease were included in this study. Motor symptoms were evaluated preoperatively, within 48 h after electrode implantation and at 6 months with United Parkinson's Disease Rating Scale part III (UPDRS-III). According to the improvement level with MLE, all participants were stratified into three groups: (1) less than 20%; (2) 20-40%, and (3) more than 40% in OFF medication states. The degree of improvement in UPDRS-III with DBS ON for each MLE group was assessed at the 6-month follow-up. Regression analysis was applied for the evaluation of the relationship between MLE and improvement with DBS ON. RESULTS: Mean results in UPDRS-III with the MLE in ON and OFF medication states were 22.1 ± 10.5 and 42.1 ± 14 points, respectively. At the 6-month follow-up, with active stimulation, results tended to further ameliorate to 14.6 (59.4%) points in ON and 20.8 (55.3%) in OFF. Mean improvement in MLE groups were: 33.6% group 1, 47.5% group 2 and 61.4% group 3. Regression analysis revealed a positive correlation between the MLE and results at 6 months with DBS ON. CONCLUSION: Results proved the presence of MLE in the early postoperative period. Furthermore, a positive correlation between MLE and improvement degree with active stimulation was observed.
BACKGROUND: Microlesion effect (MLE) is a commonly observed phenomenon after electrode insertion into the subthalamic nucleus (STN) for deep brain stimulation (DBS). OBJECTIVES: The aim of this study was to determine the presence of the MLE in the early postoperative period and the relationship between MLE and STN DBS. METHODS: 74 patients with Parkinson's disease were included in this study. Motor symptoms were evaluated preoperatively, within 48 h after electrode implantation and at 6 months with United Parkinson's Disease Rating Scale part III (UPDRS-III). According to the improvement level with MLE, all participants were stratified into three groups: (1) less than 20%; (2) 20-40%, and (3) more than 40% in OFF medication states. The degree of improvement in UPDRS-III with DBS ON for each MLE group was assessed at the 6-month follow-up. Regression analysis was applied for the evaluation of the relationship between MLE and improvement with DBS ON. RESULTS: Mean results in UPDRS-III with the MLE in ON and OFF medication states were 22.1 ± 10.5 and 42.1 ± 14 points, respectively. At the 6-month follow-up, with active stimulation, results tended to further ameliorate to 14.6 (59.4%) points in ON and 20.8 (55.3%) in OFF. Mean improvement in MLE groups were: 33.6% group 1, 47.5% group 2 and 61.4% group 3. Regression analysis revealed a positive correlation between the MLE and results at 6 months with DBS ON. CONCLUSION: Results proved the presence of MLE in the early postoperative period. Furthermore, a positive correlation between MLE and improvement degree with active stimulation was observed.
Authors: S Raymaekers; K Vansteelandt; L Luyten; C Bervoets; K Demyttenaere; L Gabriëls; B Nuttin Journal: Mol Psychiatry Date: 2016-08-02 Impact factor: 15.992
Authors: Salman E Qasim; Coralie de Hemptinne; Nicole C Swann; Svjetlana Miocinovic; Jill L Ostrem; Philip A Starr Journal: Neurobiol Dis Date: 2015-11-27 Impact factor: 5.996
Authors: Coralie de Hemptinne; Nicole C Swann; Jill L Ostrem; Elena S Ryapolova-Webb; Marta San Luciano; Nicholas B Galifianakis; Philip A Starr Journal: Nat Neurosci Date: 2015-04-13 Impact factor: 24.884
Authors: Aysegul Gunduz; Hokuto Morita; P Justin Rossi; William L Allen; Ron L Alterman; Helen Bronte-Stewart; Christopher R Butson; David Charles; Sjaak Deckers; Coralie de Hemptinne; Mahlon DeLong; Darin Dougherty; Jens Ellrich; Kelly D Foote; James Giordano; Wayne Goodman; Benjamin D Greenberg; David Greene; Robert Gross; Jack W Judy; Edward Karst; Alexander Kent; Brian Kopell; Anthony Lang; Andres Lozano; Codrin Lungu; Kelly E Lyons; Andre Machado; Hubert Martens; Cameron McIntyre; Hoon-Ki Min; Joseph Neimat; Jill Ostrem; Sat Pannu; Francisco Ponce; Nader Pouratian; Donnie Reymers; Lauren Schrock; Sameer Sheth; Ludy Shih; Scott Stanslaski; G Karl Steinke; Paul Stypulkowski; Alexander I Tröster; Leo Verhagen; Harrison Walker; Michael S Okun Journal: Int J Neurosci Date: 2015-05-25 Impact factor: 2.292
Authors: Da Un Jeong; Ji Eun Lee; Sung Eun Lee; Won Seok Chang; Sung June Kim; Jin Woo Chang Journal: Biomed Res Int Date: 2014-07-02 Impact factor: 3.411
Authors: Bernadette C M van Wijk; Martijn Beudel; Ashwani Jha; Ashwini Oswal; Tom Foltynie; Marwan I Hariz; Patricia Limousin; Ludvic Zrinzo; Tipu Z Aziz; Alexander L Green; Peter Brown; Vladimir Litvak Journal: Clin Neurophysiol Date: 2016-02-01 Impact factor: 3.708